Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States
Background. In 2018, the US Preventive Services Task Force recommended that PSA screening for prostate cancer involve men aged 55–69, based on a personal decision following consultation with a health professional. PSA screening in men aged 70 or older should only occur if symptoms exist. This study...
Saved in:
| Main Authors: | Ray M. Merrill, Seth A. Otto, Eliza B. Hammond |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Prostate Cancer |
| Online Access: | http://dx.doi.org/10.1155/2022/8646314 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01) -
Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
by: Emmanuel Nii Boye Hammond, et al.
Published: (2021-07-01) -
Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
by: Yaw Ampem Amoako, et al.
Published: (2019-04-01) -
Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
by: Yaw Ampem Amoako, et al.
Published: (2019-01-01) -
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.
by: Jae Hoon Chung, et al.
Published: (2021-01-01)